查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1850572

乳房病灶定位市場：放射導引定位、磁珠定位、超音波定位、MRI定位－全球預測，2025-2032年

Breast Lesion Localization Methods Market by Radio-guided Localization, Magnetic Seed Localization, Ultrasound Localization, MRI Localization - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，乳房病灶定位市場規模將達到 46.4 億美元，複合年成長率為 16.25%。

關鍵市場統計數據
基準年 2024 13.9億美元
預計年份：2025年 16.1億美元
預測年份 2032 46.4億美元
複合年成長率 (%) 16.25%

全面介紹現代乳房病灶定位技術，將設備技術置於臨床工作流程、操作限制和病患體驗之中。

乳房病灶定位技術的進步正在重塑診斷和手術治療路徑，使重點從純粹的技術操作轉向以患者為中心的一體化工作流程。過去，立體定位技術在手術計劃中佔據主導地位，但現代實踐強調採用微創方法，以減少手術安排上的摩擦，提高患者舒適度，並增強手術精度。臨床醫生現在通常會根據病灶在不同顯像模式下的可見性、預期的切緣、手術時間以及放射科和外科團隊之間的多學科協作來評估定位方案的選擇。

同時，設備創新和流程改進正在改變治療部位的選擇。新型無導絲定位技術使得定位可以與手術當日分開進行，診斷人員可以提前放置標記物，從而為手術團隊提供更大的排班彈性。這些變化與術中影像和導航技術的改進相輔相成，能夠即時確認切除是否徹底。因此，醫院和門診手術中心必須權衡臨床效益、員工訓練需求和營運流程調整，才能充分發揮新型定位策略的價值。

從概念到實踐的轉變需要理解支持每種技術模式的臨床證據以及決定其應用的人為因素。工作流程整合、術中病灶識別的可重複性以及與現有影像基礎設施的兼容性與設備屬性同等重要。因此，本概要的引言部分將技術選項置於臨床決策、機構限制和病患體驗的背景下進行闡述，為後續執行摘要組裝。

技術融合、影像整合和醫療服務重點如何改變臨床實踐和定位技術的應用

乳房病灶定位領域正經歷變革，這得益於多種技術的融合、臨床醫生的偏好以及醫療系統優先事項的調整。從當日導絲定位到術前數天甚至數週植入標記物的技術已發生顯著轉變，這一轉變的促進因素是患者日程安排的靈活性提高以及術中物流複雜性的降低。同時，磁性種子系統和放射引導技術也日益成熟，為解決導絲移位等問題提供了新的選擇，並實現了可靠的術中定位。

另一項重大變革是將多模態成像技術整合到術前計劃中。3D和高解析度2D超音波的進步使得對無法觸及的病灶進行更精確的定位成為可能。另一方面，對於僅在高場或開放式磁振造影序列中可見的病灶，磁振造影定位仍然至關重要。術中影像技術和導航工具進一步增強了這些影像技術的發展，提高了切緣評估的準確性，並降低了再次切除率。

供應鏈和監管動態也在影響臨床實務模式。設備製造商正在精簡產品線，以降低庫存複雜性並提高與現有手術室設備的互通性。培訓和認證途徑也在不斷發展，以使放射科醫生和外科醫生能夠安全、可重複地實施新的手術流程。最後，患者對舒適性和便利性的期望正在改變他們的選擇，因為可以在門診植入並減輕術前焦慮的微創標記越來越受到青睞。這些因素共同推動著定位方法朝著以病人為中心、以工作流程為導向的方向發展。

了解 2025 年關稅變化對營運和採購的影響，以及供應鏈韌性將如何重塑設備選擇和服務合約。

2025年的政策和貿易干預措施為乳房病灶定位醫療設備的採購和供應鏈計算引入了新的變數。影響某些類別進口醫療組件的關稅調整促使醫院和醫療設備製造商重新評估其籌資策略、庫存政策以及定位系統的總擁有成本。這促使多家醫療機構加快評估替代供應商、區域分銷商和垂直整合方案，以降低跨境成本波動的影響。

在營運方面，採購團隊調整了合約週期和交貨前置作業時間，以減輕短期供應中斷的影響。擁有集中式供應鏈管治的醫療機構實施了情境規劃，以維持醫療服務的連續性，優先採購擁有多個合格供應商和強大本地服務網路的醫療設備。同時，一些製造商重新評估了其生產地點和包裝策略，以獲得優惠貿易條件或透過貿易合規措施降低關稅負擔。

臨床醫生和管理人員現在必須考慮價格主導轉變所帶來的間接影響。設備選擇越來越不僅取決於臨床性能和易用性，還取決於供應商的可靠性、售後服務以及備件供應情況。這些因素促使醫院系統之間達成聯合採購協議，加強與供應商的合作，以確保可預測的交貨時間和培訓承諾。最終，供應鏈的韌性、合作夥伴的多元化以及營運的靈活性在設備採購決策中變得越來越重要。

基於細分的洞察表明，特定模態屬性和臨床背景決定了不同醫療環境中最佳的定位策略。

分割分析揭示了臨床和設備特定因素如何影響定位技術的應用路徑。關於放射性引導定位，我們區分了放射性導引隱匿病灶定位和放射性引導種子定位，二者各自提供不同的操作流程，並探討了影響臨床實務和人員需求的監管環境。關於磁性種子定位，我們重點介紹了兩種領先產品（Magseed 和 MaMaLoc）在檢測系統、植入體外形以及與現有手術探針的兼容性方面的差異，這要求醫療機構權衡檢測可靠性與庫存和培訓成本。關於超音波定位，我們區分了3D超音波和2D超音波，結果表明3D成像能夠提高與手術切緣的空間相關性，而2D系統因其病灶可及性和速度優勢而仍然具有吸引力。關於磁振造影定位，我們重點介紹了高場磁振造影和開放式磁振造影平台之間的差異。高場磁振造影在複雜病例中提供更優異的軟組織對比度，而開放式磁振造影則提供更高的患者舒適度和更靈活的操作方式。

這些分割差異綜合起來表明，沒有任何單一技術能夠普遍主導所有臨床場景。當放射性示蹤劑工作流程和核醫基礎設施完善時，放射性導引技術是首選；當需要將放射性種子植入與手術分開時，磁性種子植入技術具有顯著優勢；當病灶在超音波下可見時，超音波方法可以實現快速床邊定位；而對於僅能透過磁振造影（MRI）顯示的病灶或需要清晰軟組織顯像的情況，MRI定位至關重要。因此，醫療系統正日益採用多模態策略，以維持多種模態的影像能力，從而根據病灶特徵、排班需求和機構能力來客製化技術方案。

主導細分市場的洞察表明，互通性、醫護人員對多種技術的熟練掌握以及簡化的流程路徑能夠創造競爭優勢。投資於培訓、多學科診療方案和配備手術器械的術中工具的醫療機構，能夠靈活地根據患者和病灶特徵調整定位技術，從而在控制營運風險的同時，提高診療效率和患者滿意度。

區域動態和採用趨勢決定了美洲、歐洲、中東和非洲以及亞太地區的治療模式偏好和採取路徑。

區域動態決定了技術的評估、採購和實施方式。每個區域都呈現出與基礎設施、報銷標準和臨床實踐傳統相關的獨特促進因素。在美洲，對最佳化門診手術的重視促使人們迅速採用將標記物放置與手術安排脫鉤的技術。在歐洲、中東和非洲，醫療保健系統的異質性造就了不同的技術應用路徑。一些市場傾向於採用成熟的放射性示踪方法，並與核醫學緊密結合；而另一些市場則尋求磁振造影或超音波引導方案，以減少對放射性示蹤劑的依賴並應對資源限制。在亞太地區，三級醫療中心對科技的快速應用，以及對成本效益和供應鏈在地化的務實考量，促成了兼顧技術創新和營運擴充性的混合策略。

監管和報銷環境進一步加劇了區域性方法的差異。對於標記物植入和相關影像檢查，如果國家有明確的編碼和報銷政策，則更有利於這些技術的應用；而支付政策較為寬鬆的地區則往往優先考慮那些能夠體現工作流程優勢和成本控制的方法。此外，訓練系統和專業分佈也會影響檢查方式的選擇。卓越中心和教學醫院通常會率先採用先進的磁振造影（MRI）和3D超音波技術，而社區醫院則可能優先考慮那些能夠與現有放射科和手術室工作流程整合的方法。

綜上所述，這些區域性模式表明，製造商和醫療系統必須根據當地的優先事項調整其商業和部署策略。有效的市場准入需要考慮報銷途徑、臨床醫生培訓系統和供應鏈的實際情況，確保醫療器材的部署符合當地的醫療服務模式和病人的期望。

定位技術提供者之間的競爭定位和夥伴關係模式著重於整合解決方案、臨床協作和服務主導的差異化。

製造商、影像供應商和臨床網路之間的競爭與夥伴關係動態正在塑造定位技術的未來發展軌跡。設備製造商日益關注整合服務模式，將硬體、偵測探頭和培訓課程結合，以降低醫院和門診中心採用該技術的門檻。影像處理供應商和手術導引公司之間的策略聯盟正在打造捆綁式產品，簡化術中定位和邊緣評估流程，從而增強綜合解決方案相對於單一組件設備的價值提案。

同時，卓越臨床中心作為新流程檢驗和培訓的樞紐發揮著至關重要的作用。這些機構與產業夥伴合作制定臨床方案和使用者回饋機制，加速設備人體工學和檢測演算法的迭代改進。分銷合作夥伴和本地服務供應商對於市場推廣仍然至關重要，現場技術支援和法規專業知識決定部署速度。

重要的是，競爭優勢越來越依賴售後服務和數據主導的支援。能夠提供完善的培訓、維護和分析，並能證明流程一致性和設備執行時間的供應商，正贏得採購機構的更多信任。因此，市場定位正從以硬體為中心的銷售模式轉向以關係主導的模式，強調長期臨床效果、運作可靠性和共同開發的培訓路徑。

為設備製造商和供應商提供可操作的策略步驟，以透過互通性、培訓、供應鏈韌性和主導商業化來加速產品普及。

致力於加速產品推廣應用並改善臨床療效的產業領導者應採取協作策略，將產品設計、臨床醫生參與和供應鏈穩健性有機結合。首先，應優先考慮設備的互通性以及與通用術中探針和成像平台的便捷整合，以促進其在各種手術環境中的快速應用。其次，應投資於臨床醫生培訓計畫和能力提昇路徑，並透過實施多學科模擬以及放射學和外科聯合診療通訊協定，減少植入和取出技術的差異。

第三，透過認證多個通路並考慮區域性製造或組裝安排，增強供應鏈韌性，最大限度地減少跨境中斷帶來的風險。第四，重視證據的收集，優先考慮實際應用中的績效指標，例如手術效率、再次切除率和病人報告的體驗。結合以結果為導向的服務契約，這些證據將有助於建立長期的採購關係，並為臨床路徑的變更提供依據。

最後，我們根據不同地區調整商業化策略，與支付方和醫療監管機構合作，在必要時明確報銷途徑，並為資金預算有限的機構提供彈性價格設定和配套服務模式。這些措施減少了實施過程中的摩擦，協調了各相關人員的獎勵，並顯著提高了流程的一致性和病患滿意度。

結合臨床醫師訪談、臨床文獻回顧和儀器技術分析的混合研究途徑，能夠提供具有實際應用價值的見解。

本摘要的研究結合了對臨床醫生、供應鏈負責人和器械產品經理的定性訪談，以及對截至2024年中期的同行評審臨床文獻和監管指南的系統分析。訪談重點在於實際工作流程、推廣障礙和器械維護要求，以確保所獲得的見解能夠反映受控試驗環境之外的運作實際情況。此外，我們也審查了器械的技術規格和手術通訊協定，並考慮了顯像模式與術中偵測設備之間的相容性。

本調查方法盡可能強調將臨床醫生的觀點與已記錄的臨床結果和器械標籤進行三角驗證，以減少偏差並提高操作建議的可靠性。

本研究的限制包括設備迭代速度快以及報銷政策的區域差異。為了彌補這些局限性，本研究收集了採購偏好、培訓投入和供應鏈安排等領先指標，以便讀者能夠結合自身機構的實際情況來解讀研究結果。

全面總結技術、工作流程重組和供應鏈韌性如何決定成功應用和永續的臨床結果

診斷影像技術的進步、替代標記技術的出現以及對工作流程效率日益成長的關注，從根本上重塑了乳房病灶定位。臨床團隊現在擁有豐富的套件來處理不可觸及的病灶，而採用靈活的多模態策略的中心能夠更好地根據病灶特徵、時間安排限制和患者偏好調整技術。營運韌性，體現在多元化的供應商、完善的培訓計畫和可互通的設備上，已成為成功實施的關鍵決定因素。

展望未來，持續改善病患體驗和提升診療效率的關鍵在於將技術創新與務實的實施策略結合。優先考慮整合解決方案、全面培訓和可靠服務網路的製造商，將更有能力支援醫療系統從傳統工作流程轉型。顯然，醫療服務提供者必須建立完善的管治結構，對本地化方法進行評估，不僅要考慮其臨床療效，還要考慮其營運契合度、人員準備和供應鏈穩定性，從而提供更安全、更可預測的醫療服務。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 快速部署放射性種子定位技術，以提高手術精度和工作流程效率
  • 整合磁性種子定位系統可在門診實現無線病灶標靶治療
  • 將雷達反射器定位技術應用於保乳手術中的即時病灶識別
  • 碳標記技術的應用日益廣泛，該技術無需輻射暴露即可可靠地顯示病灶。
  • 擴大術中超音波引導在乳房手術的應用，以提高手術精度並減少再次切除。
  • 射頻識別標籤的出現簡化了乳房X光檢查診所的定位流程，並最大限度地減少了患者的不適感。
  • 磁振造影引導技術在緻密乳腺組織中已廣泛應用，以提高靶區識別率
  • 基於智慧感測器的病灶標記技術的創新，將手術導引平台和定位數據連接起來，實現精準治療。
  • 重點關注影響全球市場進入和普及率的報銷政策更新和監管核准。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 乳房病灶定位方法：無線引導下的市場位置估計

  • 放射線誘導隱匿性病灶定位
  • 利用無線電引導定位種子

9. 乳房病灶定位市場－磁性種子定位

  • 鎂種子
  • 媽媽搖滾

第10章 乳房病灶定位方法超音波定位

  • 3D超音波
  • 2D超音波

第11章 乳房病灶定位市場 磁振造影定位

  • 高場磁振造影
  • 開放式磁振造影

12. 乳房病灶定位市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 乳房病灶定位方法市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國乳房病灶定位市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Hologic, Inc.
    • General Electric Company
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Fujifilm Holdings Corporation
    • Canon Medical Systems Corporation
    • Samsung Electronics Co., Ltd.
    • Hitachi, Ltd.
    • Becton, Dickinson and Company
    • Merit Medical Systems, Inc.
Product Code: MRR-374DB5A06AFC

The Breast Lesion Localization Methods Market is projected to grow by USD 4.64 billion at a CAGR of 16.25% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.39 billion
Estimated Year [2025] USD 1.61 billion
Forecast Year [2032] USD 4.64 billion
CAGR (%) 16.25%

A comprehensive orientation to modern breast lesion localization that situates device technologies within clinical workflows, operational constraints, and patient experience

Advances in breast lesion localization have reshaped diagnostic and surgical care pathways, shifting emphasis from purely technical execution to integrated, patient-centered workflows. Historically, wire-based localization dominated operative planning, but contemporary practice emphasizes minimally disruptive approaches that reduce scheduling friction, improve patient comfort, and enhance surgical precision. Clinicians now routinely evaluate localization choices based on lesion visibility across imaging modalities, anticipated excision margins, procedural timing, and multidisciplinary coordination between radiology and surgery teams.

Concurrently, device innovations and procedural refinements are altering site-of-care decisions. Novel non-wire technologies permit decoupling of localization from the day of surgery, enabling diagnosticians to place markers in advance and affording surgical teams greater scheduling flexibility. These changes are complemented by improvements in intraoperative imaging and navigation that support real-time verification of excision completeness. As a result, hospitals and ambulatory surgery centers must balance clinical advantages, staff training needs, and operational redesign to capture the value of newer localization strategies.

Transitioning from concept to practice requires understanding both the clinical evidence supporting each modality and the human factors that determine adoption. Workflow integration, reproducibility of lesion identification intraoperatively, and compatibility with existing imaging infrastructure are as consequential as device characteristics. Therefore, the introduction frames the rest of this executive summary by situating technology options within clinical decision-making, institutional constraints, and patient experience considerations.

How technological convergence, imaging integration, and care delivery priorities are jointly transforming clinical practice and adoption of localization technologies

The landscape of breast lesion localization has undergone transformative shifts driven by technology convergence, clinician preference, and health system priorities. There is a discernible movement away from same-day wire localization toward techniques that permit marker placement days or weeks before surgery, a change motivated by improvements in patient scheduling flexibility and decreased intraoperative logistics complexity. In tandem, magnetic seed systems and radio-guided approaches have matured, offering alternatives that mitigate issues such as wire displacement and provide robust intraoperative detectability.

Another significant shift is the integration of multimodal imaging into preoperative planning. Advances in three-dimensional and high-resolution two-dimensional ultrasound now enable more precise localization of non-palpable lesions, while MRI localization remains indispensable for lesions visible only with high-field or open MRI sequences. These imaging developments are reinforced by intraoperative imaging technologies and navigation tools that enhance margin assessment and reduce re-excision rates.

Supply chain and regulatory dynamics have also influenced practice patterns. Device manufacturers are streamlining offerings to reduce inventory complexity and increase interoperability with existing operating room equipment. Training and credentialing pathways are evolving to ensure that radiologists and surgeons can adopt new techniques safely and reproducibly. Finally, patient expectations around comfort and convenience are reshaping adoption decisions, as minimally invasive markers that permit outpatient placement and reduce preoperative anxiety become increasingly preferred. Together, these forces are catalyzing a more patient-centric, workflow-oriented approach to localization.

Understanding the operational and procurement implications of 2025 tariff changes and how supply chain resilience reshapes device selection and service contracts

Policy and trade interventions in 2025 introduced new variables into the procurement and supply chain calculus for medical devices used in breast lesion localization. Tariff adjustments affecting certain classes of imported medical components have prompted hospitals and device manufacturers to reassess sourcing strategies, inventory policies, and total cost of ownership for localization systems. In response, several providers accelerated evaluation of alternative suppliers, regional distributors, and vertical integration options to reduce exposure to cross-border cost variability.

Operationally, procurement teams adjusted contracting cycles and delivery lead times to mitigate short-term supply disruptions. Institutions with centralized supply chain governance undertook scenario planning to preserve continuity of care, prioritizing devices with multiple certified sources and robust local service networks. At the same time, some manufacturers repositioned production footprints and packaging strategies to qualify for preferential trade terms or to reduce tariff burdens through trade compliance measures.

Clinicians and administrators must now account for the indirect impacts of tariff-driven shifts. Equipment selection decisions increasingly weigh not only clinical performance and ease of use but also supplier reliability, aftermarket service access, and spare-part availability. These considerations have accelerated collaborative sourcing agreements among hospital systems and encouraged closer engagement with vendors to secure predictable delivery and training commitments. Ultimately, the cumulative effect is a heightened emphasis on supply chain resilience, partner diversification, and operational flexibility in device adoption decisions.

Segmentation-based insights revealing how modality-specific attributes and clinical context determine optimal localization strategy across diverse care settings

Segmentation analysis clarifies how clinical and device-specific factors shape adoption pathways across localization technologies. Based on Radio-guided Localization, the landscape distinguishes radio-guided occult lesion localization and radioguided seed localization, each offering distinct procedural workflows and regulatory considerations that influence site-of-care and personnel requirements. Based on Magnetic Seed Localization, two principal product approaches typified by Magseed and MaMaLoc highlight differing detection systems, implantation profiles, and compatibility with existing surgical probes, prompting institutions to weigh detection reliability against inventory and training costs. Based on Ultrasound Localization, the differentiation between three-dimensional ultrasound and two-dimensional ultrasound underlines how volumetric imaging improves spatial correlation with intraoperative margins while two-dimensional systems remain attractive for lesion accessibility and speed. Based on MRI Localization, a contrast emerges between high-field MRI and open MRI platforms, where high-field MRI provides superior soft-tissue contrast for complex cases and open MRI affords patient comfort and broader procedural flexibility.

Synthesizing these segmentation distinctions reveals that no single technique universally dominates clinical scenarios. Instead, selection is context-dependent: radio-guided methods may be preferred when radiotracer workflows and nuclear medicine infrastructure are established; magnetic seeds are compelling where decoupling placement from surgery is prioritized; ultrasound approaches offer rapid bedside localization when lesions are sonographically visible; and MRI localization is indispensable for MRI-only lesions or when superior soft-tissue delineation is required. Consequently, health systems are increasingly adopting a pluralistic strategy, maintaining competencies across several modalities to align technique with lesion characteristics, scheduling needs, and institutional capabilities.

The segmentation-driven insight is that interoperability, staff proficiency across multiple technologies, and streamlined procedural pathways create competitive advantage. Providers that invest in training, cross-disciplinary protocols, and device-agnostic intraoperative tools can flexibly match localization method to patient and lesion attributes, thereby improving throughput and patient satisfaction while managing operational risk.

Regional dynamics and implementation realities that determine modality preference and adoption pathways across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics shape how localization technologies are evaluated, procured, and implemented, with each geography exhibiting distinct drivers related to infrastructure, reimbursement norms, and clinical practice traditions. Across the Americas, there is strong emphasis on outpatient procedure optimization and rapid adoption of technologies that decouple marker placement from surgical schedules, supported by extensive ambulatory surgical capacity and clinician interest in workflow efficiencies. In Europe, Middle East & Africa, heterogeneity across health systems creates diverse adoption pathways; some markets favor well-established radio-guided approaches where nuclear medicine integration is robust, while others pursue magnetic and ultrasound options to reduce reliance on radiotracers and to accommodate resource constraints. In the Asia-Pacific region, rapid technology adoption in tertiary centers is paired with a pragmatic focus on cost-effectiveness and supply chain localness, leading to hybrid strategies that balance innovation with operational scalability.

Regulatory and reimbursement environments further differentiate regional approaches. Countries with clear coding and reimbursement for marker placement and associated imaging facilitate broader uptake, whereas regions where payment policies are less prescriptive often prioritize methods that deliver demonstrable workflow advantages or cost containment. Additionally, training ecosystems and specialty workforce distribution influence modality preference: centers of excellence and academic hospitals frequently drive early adoption of advanced MRI and three-dimensional ultrasound techniques, while community hospitals may prioritize methods that integrate with existing radiology and operating room workflows.

Taken together, these regional patterns indicate that manufacturers and health systems must tailor commercial and implementation strategies to local priorities. Effective market engagement will account for reimbursement pathways, clinician training infrastructures, and supply chain realities to ensure that device adoption aligns with regional care delivery models and patient expectations.

Competitive positioning and partnership models that emphasize integrated solutions, clinical collaborations, and service-led differentiation among localization technology providers

Competitive and partnership dynamics among manufacturers, imaging providers, and clinical networks are shaping the future trajectory of localization technologies. Device manufacturers are increasingly focused on integrated service models that combine hardware, detection probes, and training curricula to lower the barrier to adoption for hospitals and ambulatory centers. Strategic alliances between imaging vendors and surgical navigation firms are creating bundled offerings that streamline intraoperative localization and margin assessment, reinforcing the value proposition of comprehensive solutions over single-component devices.

At the same time, clinical centers of excellence play a vital role in validating new techniques and serving as training hubs. These institutions collaborate with industry partners on clinical protocols and user feedback loops, which accelerate iterative improvements in device ergonomics and detection algorithms. Distribution partners and regional service providers remain critical to adoption in markets where on-the-ground technical support and regulatory expertise determine deployment speed.

Importantly, competitive differentiation increasingly relies on post-sale services and data-driven support. Vendors that provide robust training, maintenance, and analytics to demonstrate procedural consistency and device uptime earn greater trust from procuring organizations. Consequently, market positioning is shifting from a hardware-centric sales model to a relationship-driven approach that emphasizes long-term clinical outcomes, operational reliability, and co-developed training pathways.

Actionable strategic steps for device manufacturers and providers to accelerate adoption through interoperability, training, supply chain resilience, and evidence-driven commercialization

Industry leaders seeking to accelerate adoption and improve clinical outcomes should pursue a coordinated strategy that aligns product design, clinician engagement, and supply chain robustness. First, prioritize device interoperability and ease of integration with common intraoperative probes and imaging platforms to facilitate rapid adoption across diverse operating environments. Second, invest in clinician training programs and competency pathways that include multidisciplinary simulations and joint radiology-surgery protocols to reduce variability in implantation and retrieval techniques.

Third, strengthen supply chain resilience by qualifying multiple distribution channels and considering regional manufacturing or assembly arrangements to minimize exposure to cross-border disruptions. Fourth, emphasize evidence generation that prioritizes real-world performance measures such as procedural efficiency, re-excision incidence, and patient-reported experiences. When combined with outcome-focused service agreements, this evidence supports durable procurement relationships and justifies clinical pathway changes.

Finally, tailor commercialization approaches by region: collaborate with payers and health authorities to clarify reimbursement pathways where needed, and offer flexible pricing or bundled service models for institutions with constrained capital budgets. Together, these actions can reduce friction in adoption, align incentives across stakeholders, and deliver measurable improvements in procedural consistency and patient satisfaction.

A mixed-methods research approach combining clinician interviews, clinical literature review, and device technical analysis to inform operationally grounded insights

The research underpinning this summary integrates primary qualitative interviews with clinicians, supply chain leaders, and device product managers, combined with systematic analysis of peer-reviewed clinical literature and regulatory guidance through mid-2024. Primary interviews focused on real-world workflows, barriers to adoption, and device service requirements, ensuring that insights reflect operational realities beyond controlled trial settings. In addition, device technical specifications and surgical protocols were reviewed to map compatibility considerations across imaging modalities and intraoperative detection equipment.

Secondary evidence was synthesized from clinical journals, guideline statements, and device regulatory filings to corroborate practice patterns and technology performance attributes. Comparative analyses considered procedural steps, staff roles, and facility infrastructure needs to derive practical recommendations for adoption and implementation. Wherever possible, the methodology emphasized triangulation-aligning clinician perspectives with documented clinical outcomes and device labeling-to reduce bias and increase confidence in the operational recommendations.

Limitations of the research include the rapid pace of device iteration and the variability of regional reimbursement policies, which can alter incentive structures for adoption. To mitigate these limitations, the research captures leading indicators of adoption such as procurement preferences, training investments, and supply chain arrangements, enabling readers to interpret findings within their own institutional context.

Concluding synthesis of how technology, workflow redesign, and supply chain resilience collectively determine successful adoption and sustainable clinical outcomes

The convergence of imaging advances, alternative marker technologies, and heightened attention to workflow efficiency has fundamentally reshaped breast lesion localization. Clinical teams now have a richer toolkit to address non-palpable lesions, and institutions that adopt flexible, multimodal strategies can better match technique to lesion characteristics, scheduling constraints, and patient preferences. Operational resilience-manifested through diversified suppliers, robust training programs, and interoperable devices-emerges as a core determinant of successful implementation.

Going forward, sustained improvements in patient experience and procedural efficiency will depend on the alignment of technological innovation with pragmatic deployment strategies. Manufacturers that prioritize integrated solutions, comprehensive training, and reliable service networks will be better positioned to support health systems as they transition away from legacy workflows. For healthcare providers, the imperative is clear: implement governance structures that evaluate localization methods not only on clinical merit but also on operational fit, staff readiness, and supply chain stability, thereby delivering safer, more predictable care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rapid adoption of radioactive seed localization to improve surgical precision and workflow efficiency
  • 5.2. Integration of magnetic seed localization systems enabling wire-free lesion targeting in outpatient clinics
  • 5.3. Expansion of radar reflector localization technology for real-time lesion identification during breast conserving surgery
  • 5.4. Rising use of carbon marking techniques to provide reliable lesion visualization without radioactive exposure
  • 5.5. Increasing incorporation of intraoperative ultrasound guidance to enhance accuracy and reduce re-excisions in breast surgery
  • 5.6. Emergence of radiofrequency identification tags to streamline localization and minimize patient discomfort in mammography clinics
  • 5.7. Growing acceptance of magnetic resonance-guided localization methods for improved targeting in dense breast tissue
  • 5.8. Innovation in smart sensor-based lesion markers linking localization data with surgical navigation platforms for precision therapy
  • 5.9. Focus on reimbursement policy updates and regulatory approvals influencing market access and adoption rates globally

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Lesion Localization Methods Market, by Radio-guided Localization

  • 8.1. Radio-guided Occult Lesion Localization
  • 8.2. Radioguided Seed Localization

9. Breast Lesion Localization Methods Market, by Magnetic Seed Localization

  • 9.1. Magseed
  • 9.2. MaMaLoc

10. Breast Lesion Localization Methods Market, by Ultrasound Localization

  • 10.1. Three-Dimensional Ultrasound
  • 10.2. Two-Dimensional Ultrasound

11. Breast Lesion Localization Methods Market, by MRI Localization

  • 11.1. High-Field MRI
  • 11.2. Open MRI

12. Breast Lesion Localization Methods Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Breast Lesion Localization Methods Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Breast Lesion Localization Methods Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Hologic, Inc.
    • 15.3.2. General Electric Company
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. Koninklijke Philips N.V.
    • 15.3.5. Fujifilm Holdings Corporation
    • 15.3.6. Canon Medical Systems Corporation
    • 15.3.7. Samsung Electronics Co., Ltd.
    • 15.3.8. Hitachi, Ltd.
    • 15.3.9. Becton, Dickinson and Company
    • 15.3.10. Merit Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BREAST LESION LOCALIZATION METHODS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BREAST LESION LOCALIZATION METHODS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED OCCULT LESION LOCALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED OCCULT LESION LOCALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED OCCULT LESION LOCALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED OCCULT LESION LOCALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED OCCULT LESION LOCALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED OCCULT LESION LOCALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOGUIDED SEED LOCALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOGUIDED SEED LOCALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOGUIDED SEED LOCALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOGUIDED SEED LOCALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOGUIDED SEED LOCALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOGUIDED SEED LOCALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGSEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGSEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGSEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGSEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGSEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGSEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAMALOC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAMALOC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAMALOC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAMALOC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAMALOC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAMALOC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY THREE-DIMENSIONAL ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY THREE-DIMENSIONAL ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY THREE-DIMENSIONAL ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY THREE-DIMENSIONAL ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY THREE-DIMENSIONAL ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY THREE-DIMENSIONAL ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TWO-DIMENSIONAL ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TWO-DIMENSIONAL ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TWO-DIMENSIONAL ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TWO-DIMENSIONAL ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TWO-DIMENSIONAL ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TWO-DIMENSIONAL ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HIGH-FIELD MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HIGH-FIELD MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HIGH-FIELD MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HIGH-FIELD MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HIGH-FIELD MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HIGH-FIELD MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY OPEN MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY OPEN MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY OPEN MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY OPEN MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY OPEN MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY OPEN MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 65. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 67. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 69. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 71. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 76. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 78. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 80. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 82. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 86. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 88. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 90. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 92. LATIN AMERICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 103. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 106. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 107. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 108. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 109. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 110. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 111. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 112. EUROPE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 116. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 118. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 120. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 122. MIDDLE EAST BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 123. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 126. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 127. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 128. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 129. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 130. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 131. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 132. AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 148. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 149. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 150. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 151. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 152. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 153. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 154. ASEAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 155. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 158. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 159. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 160. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 161. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 162. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 163. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 164. GCC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 175. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 178. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 179. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 180. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 181. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 182. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 183. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 184. BRICS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 185. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 188. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 189. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 190. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 191. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 192. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 193. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 194. G7 BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 195. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 198. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 199. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 200. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 201. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 202. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 203. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 204. NATO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 209. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 211. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 213. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 215. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 216. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 217. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 218. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 219. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 220. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 221. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 222. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 223. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 224. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 225. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 226. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 227. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 228. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 229. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 230. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 231. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 232. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 233. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 234. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 235. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 236. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 237. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 238. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 247. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 249. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 251. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 253. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 255. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 256. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 257. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 259. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 261. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 263. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 264. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 265. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 266. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 267. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 268. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 269. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 270. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 271. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 272. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIO-GUIDED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 273. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 274. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC SEED LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 275. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 276. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND LOCALIZATION, 2025-2032 (USD MILLION)
  • TABLE 277. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MRI LOCALIZATION, 2018-2024 (USD MILLION)
  • TABLE 278. ITALY BREAST